4.7 Article

pH-Responsive chitosan-modified gadolinium oxide nanoparticles delivering 5-aminolevulinic acid: A dual cellular and metabolic T1-T2*contrast agent for glioblastoma brain tumors detection

Journal

JOURNAL OF MOLECULAR LIQUIDS
Volume 368, Issue -, Pages -

Publisher

ELSEVIER
DOI: 10.1016/j.molliq.2022.120628

Keywords

Glioblastoma multiforme; 5-aminolevulinic acid; Gadolinium oxide nanoparticles; Cellular and metabolic imaging

Funding

  1. National Institute for Medical Research Development (NIMAD) , Iran
  2. [977114]

Ask authors/readers for more resources

In this study, gadolinium oxide nanoparticles (Gd2O3 NPs) were loaded with 5-aminolevulinic acid (5-ALA) and assisted by intracellular iron, resulting in their ability to serve as a T1 contrast agent with T2* contrast ability. The NPs exhibited concentration-dependent toxicity against glioblastoma C6 cells and showed higher relaxation rates (R1 and R2*) compared to the controls. These findings suggest that Gd2O3 NPs loaded with 5-ALA and assisted by intracellular iron could be a promising contrast agent for glioblastoma diagnosis in MRI.
Diagnosis of glioblastoma multiforme (GBM) with high sensitivity and specificity requires cellular and metabolic imaging. In this study, we aimed to endow gadolinium oxide nanoparticles (Gd2O3 NPs) as an interesting T1 contrast agent with T2* contrast ability through intracellular iron assistance induced by 5-aminolevulinic acid (5-ALA) with ferric ammonium citrate (FAC). Chitosan (CS)-loaded Gd2O3 NPs were loaded with 5-aminolevulinic acid (Gd2O3/CS-TPP@5-ALA NPs), and then evaluated as a pH-responsive dual cellular and metabolic T1 and T2* contrast agent for GBM diagnosis. The target NPs with an average size of 138 nm revealed concentration-dependent toxicity against glioblastoma C6 cells. The relaxation rate (R1) of the C6 cells treated with Gd2O3/CS-TPP@5-ALA NPs plus FAC was remarkably higher than the controls including Gd2O3/CS-TPP NPs, Gd2O3/CS-TPP@5-ALA NPs, and FAC (17.2 +/- 2.4 vs. 8 +/- 1.5, 8.4 +/- 1.2, and 2.3 +/- 0.5, respectively). Interestingly, the transverse relaxation rate (R2*) of the C6 cells trea-ted with Gd2O3/CS-TPP@5-ALA NPs + FAC was significantly higher than the controls including Gd2O3/CS-TPP NPs, Gd2O3/CS-TPP@5-ALA NPs, and FAC (96 +/- 8 vs. 25 +/- 4, 27 +/- 5, and 19 +/- 2.6, respectively). We believe that Gd2O3/CS-TPP@5-ALA NPs + FAC could be introduced as promising dual cellular and meta-bolic T1-T2* contrast agents for GBM diagnosis in MRI.(c) 2022 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available